Evaluation of the efficacy of rectal preparation from Hemoheal® Cream in patients with Hemorrhoid
- Conditions
- Hemorrohiod.Unspecified haemorrhoids with other complications
- Registration Number
- IRCT2017091335460N1
- Lead Sponsor
- Vice Chancellor for Research, Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Age>18
Patients who sign the testimonials and cooperate during the study
Patients who their diseases are confirmed by complete medical evaluation including colonoscopy, pathology and laboratory data
Only patients with mild to moderate hemorrhoids can be included in this study
Patients who were not cured with Hemoheal cream during the last month
4th-degree hemorrhoids
Pregnant patients and nursing mothers
Patients who have to use other drugs that interference with this medication
Previous history of anorectal surgery
Patients who are suffering from other diseases in addition to hemorrhoids, such as apparent coagulation abnormalities or kidney impairment accompanied with colorectal diseases such as cancer, Crohn's disease, ulcerative colitis, anal fistula, anal fissure, proctitis or perineal skin inflammation
Patients who are disposed to a serious health danger, such as severe cardiac, liver or renal diseases
If significant side effects occur, the patient will be excluded from the study and followed to end of the study
Patients with severe allergy to this plant (dermatitis contact)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of excretion daily. Timepoint: Before using the drug; 2 weeks after using the drug-30 days after using the drugs. Method of measurement: Based on Hemorrohiod clinic questionary.;Rate of rectal bleeding. Timepoint: before using the drug; 2 weeks after using the drug-30 days after using the drugs. Method of measurement: based on Hemorrohiod clinic score.
- Secondary Outcome Measures
Name Time Method Gastrointestinal disorders. Timepoint: Two weeks after using the drug; 30 days after using the drug. Method of measurement: Based on side effect questionary.